Welcome to MyStrategist, the digital home for MedTech Strategist.

MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Investors & Dealmaking

415 CAPITAL: Informing Early-Stage Investing with Distribution Expertise

While the combination of distributor and investor seems an unlikely one, the principals of 415 CAPITAL believe that their historic role as one of Germany’s leading distributors of cardiovascular technologies gives them a special insight into the opportunities start-ups face, insights that few early-stage investors have.

Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Start-Ups

NeuTigers Brings Edge Computing to COVID Detection

NeuTigers’ miniaturized neural networks allow wearable point-of-care devices like wristwatches to collect and analyze data on the spot. The first application among many possible is a new screening method for COVID-19 infection.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Executive Interviews

Glooko’s Russ Johannesson on How the Pandemic is Transforming Diabetes Care

Glooko, which operates one of the largest remote patient monitoring platforms for the diabetes community, has a unique window on how the pandemic has altered patient care paradigms. In this Q&A, CEO Russ Johannesson shares his perspectives on the “systemic change” driving the adoption and acceptance of remote care and the lasting impact of this shift.

Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.

Subscribe   Free Premier Issue   Learn More
More From MedTech Strategist:

Next-Gen Synthetic Sealants and Glues: Shifting the Surgical Paradigm

The surgical toolbox is constantly evolving, and next-generation surgical sealants and glues could play an essential role in the near future. Of particular interest are several products in late-stage development that aim to fill an unmet need for safe and highly effective tissue sealing inside the body. Two young companies in this space, BioControl and Cohera Medical, are taking aim at several high-risk, high-volume surgical procedures.

Read Article